中国卒中杂志 ›› 2019, Vol. 14 ›› Issue (06): 612-618.DOI: 10.3969/j.issn.1673-5765.2019.06.018
张昌林,倪小佳,林浩,吴俊标,李春花,黎劭学,蔡业峰
收稿日期:
2018-08-25
出版日期:
2019-06-20
发布日期:
2019-06-20
通讯作者:
倪小佳 grace1984325@126.com
Received:
2018-08-25
Online:
2019-06-20
Published:
2019-06-20
摘要:
蛛网膜下腔出血(subarachnoid hemorrhage,SAH)是临床上常见的脑血管病急危重症,具有 高致死率和高致残率的特点。尽管药物和血管内治疗不断进步,SAH患者功能预后的改善仍是目前面 临的一大难题。现研究已表明SAH脑血管痉挛,氧化应激反应,炎症反应,血脑屏障破坏与脑水肿, 细胞凋亡、焦亡与坏死,细胞自噬,皮质传播抑制和微血栓形成等病理变化过程是影响患者临床转 归的潜在机制。本文就SAH病理生理机制进行综述,以期为SAH临床预防、治疗和药物研发提供参考 依据。
张昌林,倪小佳,林浩,吴俊标,李春花,黎劭学,蔡业峰. 蛛网膜下腔出血病理生理机制研究进展[J]. 中国卒中杂志, 2019, 14(06): 612-618.
ZHANG Chang-Lin, NI Xiao-Jia,LIN Hao, WU Jun-Biao, LI Chun-Hua, LI Shao-Xue, CAI Ye-Feng. Advance in Pathophysiological Mechanism of Subarachnoid Hemorrhage[J]. Chinese Journal of Stroke, 2019, 14(06): 612-618.
[1] LAWTON M T,VATES G E. Subarachnoidhemorrhage[J]. N Engl J Med,2017,377(3):257-266.[2] Brisman J L,Mayberg M R. SubarachnoidHemorrhage[M]//Goldstein L B. A primer on strokeprevention treatment:an overview based on AHA/ASA guidelines. New Jersey:Wiley-Blackwell,2013:65-84.[3] SOLTER V V,ROJE-BEDEKOVI? M,BREITENFELD T,et al. Recommendations for themanagement of medical complications in patientsfollowing aneurysmal subarachnoid hemorrhage[J].Acta Clin Croat,2014,53(1):113-138.[4] WU L,CHEN G. Signaling Pathway in CerebralVasospasm After Subarachnoid Hemorrhage:NewsUpdate[J/OL]. Acta Neurochir Suppl,2016,121:161-165. https://doi.org/10.1007/978-3-319-18497-5_29.[5] CIUREA A V,PALADE C,VOINESCU D,et al.Subarachnoid hemorrhage and cerebral vasospasm --Literature review[J]. J Med Life,2013,6(2):120-125.[6] KOIDE M,WELLMAN G C. SAH-induced MMPactivation and K V current suppression is mediatedvia both ROS-dependent and ROS-independentmechanisms[J/OL]. Acta Neurochir Suppl,2015,120:89-94. https://doi.org/10.1007/978-3-319-04981-6_15.[7] CROCI D,NEVZATI E,DANURA H,et al. Therelationship between IL-6,ET-1 and cerebralvasospasm,in experimental rabbit subarachnoidhemorrhage[J]. J Neurosurg Sci,2019,63(3):245-250.[8] HOSTENBACH S,D'HAESELEER M,KOOIJMAN R,et al. The pathophysiological roleof astrocytic endothelin-1[J/OL]. Prog Neurobiol,2016,144:88-102. https://doi.org/10.1016/j.pneurobio.2016.04.009.[9] MUNAKATA A,NARAOKA M,KATAGAI T,etal. Role of cyclooxygenase-2 in relation to nitricoxide and endothelin-1 on pathogenesis of cerebralvasospasm after subarachnoid hemorrhage inrabbit[J]. Transl Stroke Res,2016,7(3):220-227.[10] RASMUSSEN R,JUHLER M,WETTERSLEVJ. Effects of continuous prostacyclin infusionon regional blood flow and cerebral vasospasmfollowing subarachnoid haemorrhage:statisticalanalysis plan for a randomized controlled trial[J].Trials,2012,15:228. https://doi.org/10.1186/1745-6215-15-228.[11] FATHI A R,BAKHTIAN K D,PLUTA R M. Therole of nitric oxide donors in treating cerebralvasospasm after subarachnoid hemorrhage[J]. ActaNeurochir Suppl,2011,110(Pt 1):93-97.[12] ANSAR S,SVENDGAARD N A,EDVINSSONL. Neurokinin-1 receptor antagonism in a ratmodel of subarachnoid hemorrhage:preventionof upregulation of contractile ETB and 5-HT1Breceptors and cerebral blood flow reduction[J]. J Neurosurg,2007,106(5):881-886.[13] HEINSBERG L W,TURI E,REN D,et al.Evaluation of APOE genotype and ability to performactivities of daily living following aneurysmalsubarachnoid hemorrhage[J]. Biol Res Nurs,2018,20(2):177-182.[14] WU H T,ZHANG X D,SU H,et al. Associationof apolipoprotein E polymorphisms with cerebralvasospasm after spontaneous subarachnoidhemorrhage[J]. Acta Neurochir Suppl,2011,110(Pt1):141-144.[15] KANTOR E,BAYIR H,REN D,et al. Haptoglobingenotype and functional outcome after aneurysmalsubarachnoid hemorrhage[J]. J Neurosurg,2014,120(2):386-390.[16] YANG Y,CHEN S,ZHANG J M. The Updated roleof oxidative stress in subarachnoid hemorrhage[J].Curr Drug Deliv,2017,14(6):832-842.[17] LEE J Y,KEEP R F,HE Y,et al. Hemoglobinand iron handling in brain after subarachnoidhemorrhage and the effect of deferoxamine on earlybrain injury[J]. J Cereb Blood Flow Metab,2010,30(11):1793-1803.[18] LOFTSPRING M C. Iron and early brain injury aftersubarachnoid hemorrhage[J]. J Cereb Blood FlowMetab,2010,30(11):1791-1792.[19] YAN H,HAO S,SUN X,et al. Blockageof mitochondrial calcium uniporter preventsiron accumulation in a model of experimentalsubarachnoid hemorrhage[J]. Biochem Biophys ResCommun,2015,456(4):835-840.[20] ZHOU K,SHI L,WANG Z,et al. RIP1-RIP3-DRP1pathway regulates NLRP3 inflammasome activationfollowing subarachnoid hemorrhage[J/OL]. ExpNeurol,2017,295:116-124. https://doi.org/10.1016/j.expneurol.2017.06.003.[21] HANAFY K A. The role of microglia andthe TLR4 pathway in neuronal apoptosis andvasospasm after subarachnoid hemorrhage[J/OL].J Neuroinflammation,2013,10:868. https://doi.org/10.1186/1742-2094-10-83.[22] SHAO A,WU H,HONG Y,et al. Hydrogenrichsaline attenuated subarachnoid hemorrhageinducedearly brain injury in rats by suppressinginflammatory response:possible involvement ofNF-κB pathway and NLRP3 inflammasome[J]. MolNeurobiol,2016,53(5):3462-3476.[23] MADDAHI A,POVLSEN G K,EDVINSSON L.Regulation of enhanced cerebrovascular expressionof proinflammatory mediators in experimentalsubarachnoid hemorrhage via the mitogen-activatedprotein kinase kinase/extracellular signal-regulatedkinase pathway[J/OL]. J Neuroinflammation,2012,9:274. https://doi.org/10.1186/1742-2094-9-274.[24] NI W,GU Y X,SONG D L,et al. The relationshipbetween IL-6 in CSF and occurrence of vasospasmafter subarachnoid hemorrhage[J]. Acta NeurochirSuppl,2011,110(Pt 1):203-208.[25] SEHBA F A,HOU J,PLUTA R M,et al. Theimportance of early brain injury after subarachnoidhemorrhage[J]. Prog Neurobiol,2012,97(1):14-37.[26] AYER R,JADHAV V,SUGAWARA T,et al.The Neuroprotective Effects of Cyclooxygenase-2Inhibition in a Mouse Model of AneurysmalSubarachnoid Hemorrhage[J/OL]. ActaNeurochir Suppl,2011,111:145-149. https://doi.org/10.1007/978-3-7091-0693-8_24.[27] DONG Y,FAN C,HU W,et al. Melatoninattenuated early brain injury induced bysubarachnoid hemorrhage via regulating NLRP3inflammasome and apoptosis signaling[J]. J PinealRes,2016,60(3):253-262.[28] CROWLEY R W,MEDEL R,KASSELL N F,et al.New insights into the causes and therapy of cerebralvasospasm following subarachnoid hemorrhage[J].Drug Discov Today,2008,13(5-6):254-260.[29] LIU W,HENDREN J,QIN X J,et al. Normobarichyperoxia attenuates early blood-brain barrierdisruption by inhibiting MMP-9-mediated occludindegradation in focal cerebral ischemia[J]. JNeurochem,2009,108(3):811-820.[30] LI Z,LIANG G,MA T,et al. Blood-brain barrierpermeability change and regulation mechanism aftersubarachnoid hemorrhage[J]. Metab Brain Dis,2015,30(2):597-603.[31] FUJII M,DURIS K,ALTAY O,et al. Inhibitionof Rho kinase by hydroxyfasudil attenuates brainedema after subarachnoid hemorrhage in rats[J].Neurochem Int,2012,60(3):327-333.[32] LEINONEN V,VANNINEN R,RAURAMAA T.Raised intracranial pressure and brain edema[J/OL].Handb Clin Neurol,2017,145:25-37. https://doi.org/10.1016/B978-0-12-802395-2.00004-3.[33] ORAKCIOGLU B,FIEBACH J B,STEINER T,etal. Evolution of early perihemorrhagic changes--ischemia vs . edema:an MRI study in rats[J]. ExpNeurol,2005,193(2):369-376.[34] FRIEDRICH V,FLORES R,SEHBA F A. Celldeath starts early after subarachnoid hemorrhage[J].Neurosci Lett,2012,512(1):6-11.[35] SEKERDAG E,SOLAROGLU I,GURSOYOZDEMIRY. Cell death mechanisms in stroke and novel molecular and cellular treatment options[J].Curr Neuropharmacol,2018,16(9):1396-1415.[36] HASEGAWA Y,SUZUKI H,SOZEN T,et al.Apoptotic mechanisms for neuronal cells in earlybrain injury after subarachnoid hemorrhage[J]. ActaNeurochir Suppl,2011,110(Pt 1):43-48.[37] YUKSEL S,TOSUN Y B,CAHILL J,et al. Earlybrain injury following aneurysmal subarachnoidhemorrhage:emphasis on cellular apoptosis[J]. TurkNeurosurg,2012,22(5):529-533.[38] DAI Y,ZHANG W,ZHOU X,et al. Activationof the protein kinase B(Akt)reduces Nur77-induced Apoptosis during early brain injury afterexperimental subarachnoid hemorrhage in rat[J].Ann Clin Lab Sci,2015,45(6):615-622.[39] 刘进平,夏勇,李进,等. 血浆游离mtDNA及脑组织TLR-9/MAPK的表达在蛛网膜下腔出血中的意义[J].四川大学学报(医学版),2017,48(2):225-229.[40] CHEN Y,HUANG L,ZHANG H,et al. Reductionin autophagy by(-)-Epigallocatechin-3-Gallate(EGCG):a potential mechanism of preventionof mitochondrial dysfunction after subarachnoidhemorrhage[J]. Mol Neurobiol,2017,54(1):392-405.[41] ROUSSEL B D,KRUPPA A J,MIRANDA E,et al.Endoplasmic reticulum dysfunction in neurologicaldisease[J]. Lancet Neurol,2013,12(1):105-118.[42] SHI L,WANG Z,LIU X,et al. Bax inhibitor-1 isrequired for resisting the early brain injury inducedby subarachnoid hemorrhage through regulatingIRE1-JNK pathway[J]. Neurol Res,2018,40(3):189-196.[43] SANGIULIANO B,PÉREZ N M,MOREIRA DF,et al. Cell death-associated molecular-patternmolecules:inflammatory signaling and control[J/OL]. Mediators Inflamm,2014,2014:821043. https://doi.org/10.1155/2014/821043.[44] LOSSI L,CASTAGNA C,MERIGHI A. Neuronalcell death:an overview of its different forms incentral and peripheral neurons[J/OL]. Methods MolBiol,2015,1254:1-18. https://doi.org/10.1007/978-1-4939-2152-2_1.[45] SHALINI S,DORSTYN L,DAWAR S,et al. Old,new and emerging functions of caspases[J]. CellDeath Differ,2015,22(4):526-539.[46] CAHILL J,CALVERT J W,ZHANG J H,et al.Mechanisms of early brain injury after subarachnoidhemorrhage[J]. J Cereb Blood Flow Metab,2006,26(11):1341-1353.[47] STAMOULA E,VAVILIS T,AGGELIDOU E,etal. Low dose administration of glutamate triggers anon-apoptotic,autophagic response in PC12 cells[J].Cell Physiol Biochem,2015,37(5):1750-1758.[48] HARRIS H,RUBINSZTEIN D C. Control ofautophagy as a therapy for neurodegenerativedisease[J]. Nat Rev Neurol,2011,8(2):108-117.[49] GALLUZZI L,BRAVO-SAN PEDRO J M,BLOMGREN K,et al. Autophagy in acute braininjury[J]. Nat Rev Neurosci,2016,17(8):467-484.[50] WANG Z,SHI X Y,YIN J,et al. Role of autophagyin early brain injury after experimental subarachnoidhemorrhage[J]. J Mol Neurosci,2012,46(1):192-202.[51] KRAMER D R,FUJII T,OHIORHENUAN I,et al.Cortical spreading depolarization:pathophysiology,implications,and future directions[J/OL]. J ClinNeurosci,2015,24:22-27. https://www.doi.org/10.1016/j.jocn.2015.08.004.[52] NOZARI A,DILEKOZ E,SUKHOTINSKY I,etal. Microemboli may link spreading depression,migraine aura,and patent foramen ovale[J]. AnnNeurol,2010,67(2):221-229.[53] TYKOCKI T,KOSTYRA K,BOJANOWSKI K,etal. Analysis of the serum components in acute periodafter subarachnoid hemorrhage[J]. Turk Neurosurg,2014,24(5):672-678.[54] HÜBEL N,HOSSEINI-ZARE M S,?IBURKUSJ,et al. The role of glutamate in neuronalion homeostasis:a case study of spreadingdepolarization[J/OL]. PLoS Comput Biol,2017,13(10):e1005804. https://doi.org/10.1371/journal.pcbi.1005804.[55] FRIEDRICH B,MÜLLER F,FEILER S,et al.Experimental subarachnoid hemorrhage causesearly and long-lasting microarterial constriction andmicrothrombosis:an in-vivo microscopy study[J]. JCereb Blood Flow Metab,2012,32(3):447-455.[56] SABRI M,AI J,LAKOVIC K,et al. Mechanismsof microthrombi formation after experimentalsubarachnoid hemorrhage[J/OL]. Neuroscience,2012,224:26-37. https://doi.org/10.1016/j.neuroscience.2012.08.002. |
[1] | 赵鑫, 薛伟, 祝新莉, 井冬青, 洪帆, 郭筱, 刘君玲. 阵发性睡眠性血红蛋白尿症伴可逆性后部脑病综合征1例报道[J]. 中国卒中杂志, 2024, 19(6): 699-705. |
[2] | 王超, 胡永珍, 李雪松. 动脉瘤性蛛网膜下腔出血后分流依赖性脑积水的预测研究进展[J]. 中国卒中杂志, 2024, 19(1): 87-93. |
[3] | 程忻, 仲伟逸, 董漪, 李琦, 倪伟, 谷鸿秋, 顾宇翔, 董强, 中国卒中学会中国脑血管病临床管理指南撰写工作委员会. 中国脑血管病临床管理指南(第2版)(节选)——第6章 蛛网膜下腔出血临床管理推荐意见[J]. 中国卒中杂志, 2023, 18(9): 1024-1029. |
[4] | 李光硕, 赵性泉. 英国国家卒中临床指南2023版要点及解读——出血性卒中[J]. 中国卒中杂志, 2023, 18(12): 1365-1369. |
[5] | 刘洋, 冯光. 目标温度管理在高分级动脉瘤性蛛网膜下腔出血患者中的应用进展[J]. 中国卒中杂志, 2023, 18(11): 1307-1314. |
[6] | 霍洁, 陈必耀, 张初吉, 徐玢, 冀瑞俊. 影像学改变及意识障碍与蛛网膜下腔出血继发脑心综合征的相关性研究[J]. 中国卒中杂志, 2023, 18(07): 811-816. |
[7] | 贺欣, 赵东红, 闫莹, 范艳竹. 蛛网膜下腔出血腰椎穿刺术后患者体位管理新模式的应用效果分析[J]. 中国卒中杂志, 2023, 18(05): 572-576. |
[8] | 刘健伟, 甄勇, 宋炳伟, 程矫, 耿平, 胡建兵. 高分级动脉瘤性蛛网膜下腔出血患者术后肺炎病原学及耐药性分析 [J]. 中国卒中杂志, 2023, 18(01): 83-89. |
[9] | 程实, 李静, 郭军平, 胡爱香, 于鑫玮, 韩玮, 梁瑛, 张越巍, 冀瑞俊. 急性卒中患者住院期间感染的临床特征及危险因素分析[J]. 中国卒中杂志, 2022, 17(10): 1065-1070. |
[10] | 吴倩, 陶立元, 陈思琪, 钟莲梅, 刘丽萍, 米东华. 血糖波动对动脉瘤性蛛网膜下腔出血后迟发性脑缺血及30天死亡的影响 [J]. 中国卒中杂志, 2022, 17(08): 845-850. |
[11] | 王拥军, 李子孝, 谷鸿秋, 翟屹, 姜勇, 周齐, 赵性泉, 王伊龙, 杨昕, 王春娟, 孟霞, 李昊, 刘丽萍, 荆京, 吴静, 徐安定, 董强, David Wang, 王文志, 马旭东, 赵继宗, 《中国卒中报告》编写委员会(第一作者). 中国卒中报告2020(中文版)(3)[J]. 中国卒中杂志, 2022, 17(07): 675-682. |
[12] | 王拥军, 李子孝, 谷鸿秋, 翟屹, 姜勇, 周齐, 赵性泉, 王伊龙, 杨昕, 王春娟, 孟霞, 李昊, 刘丽萍, 荆京, 吴静, 徐安定, 董强, David Wang, 王文志, 马旭东, 赵继宗, 《中国卒中报告》编写委员会(第一作者). 中国卒中报告2020(中文版)(2)[J]. 中国卒中杂志, 2022, 17(06): 553-567. |
[13] | 王拥军, 李子孝, 谷鸿秋, 翟屹, 姜勇, 周齐, 赵性泉, 王伊龙, 杨昕, 王春娟, 孟霞, 李昊, 刘丽萍, 荆京, 吴静, 徐安定, 董强, David Wang, 王文志, 马旭东, 赵继宗, 《中国卒中报告》编写委员会(第一作者). 中国卒中报告2020(中文版)(1)[J]. 中国卒中杂志, 2022, 17(05): 433-447. |
[14] | 张霞, 余正阳, 于丹丹, 田德财, 杨中华, 刘丽萍. 2例小脑幕区硬脑膜动静脉瘘误诊病例报告[J]. 中国卒中杂志, 2022, 17(04): 398-401. |
[15] | 吴娟娟, 倪俊. 脑淀粉样血管病发病机制的研究进展[J]. 中国卒中杂志, 2021, 16(12): 1278-1283. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||